Skip to content
Screener

Amneal Pharmaceuticals, Inc. AMRX Specialty — Employee compensation and benefits

Other segment segments

Affordable Medicines
$12.02M-18.2%

Similar metrics at other companies

Lowe's Companies logo
LOWReportable Segment — Employee compensation and benefits
13.4%-0.1pp
Asset Entities logo
ASSTCorporate & Other — Employee compensation and benefits
$6.58M
Asset Entities logo
ASSTMedical Device — Employee compensation and benefits
$5.18M
Beneficient logo
BENFBen Custody — Employee compensation and benefits
$650K+121%
Beneficient logo
BENFBen Liquidity — Employee compensation and benefits
$464K+31.4%
Houlihan Lokey logo
HLIFinancial Restructuring — Employee compensation and benefits
$70.69M-20.8%

Other financials

Income statement

See full
Revenue$796.2M+9.9%
Gross profit$334.5M+16.9%
Operating income$129.8M+16.5%
Net income$57.7M+157%
EPS (diluted)$0.18+157%

Balance sheet

See full
Cash & equivalents$127.6M+78.4%
Total debt$2.6B+18.0%
Total equity$33.0M+129%
Total assets$3.8B+10.3%

Cash flow

See full
Operating cash flow-$21.2M-125%
CapEx$30.7M+34.5%
Free cash flow-$51.9M-185%

Valuation

See full
Market cap$5.77B+129%
Enterprise value$8.21B+77.4%
P/E36.7×-711×
P/S1.9×+1.0×

Profitability

See full
Gross margin39.3%+1.7pp
Operating margin14.6%+1.4pp
Net margin5%+4.9pp
FCF margin4.1%-5.8pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity77.8×
Current ratio2.2×+0.8×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.

The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001723128-26-000031
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Employee compensation and benefits$12,938$10,791$24,873$21,663
Product marketing13,9919,88421,80817,895
Commercial operations and salesforce11,6028,78725,37519,578
Other (1)1,5648522,7302,156
Total$40,095$30,314$74,786$61,292

Item 1. Financial Statements (Unaudited)

FAQ

What is Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits?
Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — employee compensation and benefits of $12.94M in Q2 2026.
How has Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits changed year-over-year?
Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits increased by 19.9% year-over-year, from $10.79M to $12.94M.
What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits?
Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits has grown at a 7.8% compound annual growth rate (CAGR), from $34.89M to $43.71M.
What does specialty — employee compensation and benefits mean?
Includes all salary, wages, and benefit-related costs for personnel dedicated to the specialty segment. This metric helps assess the human capital investment required to support the segment's commercial and operational activities.

Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — employee compensation and benefits.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude